Functional Basal-like Cell Generation via SMAD Pathway Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for directing the differentiation of pluripotent stem cells into specific tissue types, such as lung tissue, lack precision and efficiency in controlling cell fate, particularly in generating functional basal-like cells, which are crucial for regenerative medicine and understanding lung development and disease.
Innovation Solution
Activating the SMAD signaling pathway via TGFβ1 and BMP4 in pluripotent stem cell-derived lung bud tip progenitor organoid tissue to induce the formation of functional basal-like cells, which exhibit clonal expansion, self-renewal, and multilineage differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional differentiation methods are used for pluripotent stem cells, then general tissue formation occurs, but precision and efficiency in generating specific functional basal-like cells is poor
Solution Approach 1:
The patent applies parameter changes by systematically varying signaling pathway activators (TGFβ1, BMP4) and their concentrations to control cell differentiation. By adjusting these biochemical parameters, the method achieves precise generation of functional basal-like cells with improved both precision and efficiency compared to conventional differentiation approaches
Solution Approach 2:
The patent uses SMAD signaling pathway components as intermediaries to transmit differentiation signals. TGFβ1 and BMP4 activate SMAD proteins that mediate the conversion of pluripotent stem cells into functional basal-like cells, providing a controlled mechanism that enhances both precision and efficiency of differentiation
2Productivity
If activation of SMAD signaling via TGFβ1 and BMP4 is used, then functional basal-like cells are robustly induced, but the complexity of the differentiation protocol increases
Solution Approach 1:
The patent merges multiple signaling pathway activators (TGFβ1 and BMP4) into a single coordinated treatment protocol. By combining these activators that converge on the SMAD pathway, the method achieves robust induction of functional basal-like cells while managing protocol complexity through integrated rather than separate treatments
Solution Approach 2:
The patent employs the SMAD signaling pathway as a universal mechanism that responds to multiple activators (TGFβ1, BMP4). This multi-functional approach allows a single signaling pathway to orchestrate the differentiation process, achieving robust cell induction without requiring entirely separate mechanisms for each signal
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a robust and efficient in vitro system for generating functional basal-like cells, enhancing our understanding of lung development and offering implications for regenerative medicine and basal cell development in other organs.
Implementation Method 1
Activating the SMAD signaling pathway via activation of TGFβ1 (and/or the TGFβ signaling pathway) and BMP4 (and/or the BMP signaling pathway)
Data Source
AI summary
The invention disclosed herein generally relates to methods and systems for converting stem cells into specific tissue(s) or cells through directed differentiation. In particular, the invention disclosed herein relates to methods and systems for promoting functional basal-like cells from pluripotent stem cell-derived lung bud tip progenitor organoid tissue through activation of SMAD signaling via activation of TGFβ1 (and/or the TGFβ signaling pathway) and BMP4 (and/or the BMP signaling pathway).


